Kidney (Renal Cell) Cancer
Featured Articles
(BioSpace) Nov 6, 2018 - Cambridge, Mass.-based AVEO Oncology hit the mark in its Phase III study of a treatment for highly refractory advanced or metastatic renal cell carcinoma (RCC). The company said its drug tivozanib met its primary endpoint of demonstrating a statistically significant benefit in progression-free survival (PFS)....
Read Article
(Xconomy New York) Oct 18, 2018 - Merck could soon join rival Bristol-Myers Squibb in making immunotherapy an option for kidney cancer patients who have never had treatment before. Merck reported today that its blockbuster pembrolizumab (Keytruda) has hit its marks much earlier than expected in an 861-person Phase 3 study called...
Read Article
Latest Articles
November 19, 2018
November 06, 2018
November 01, 2018
October 23, 2018
October 23, 2018
October 23, 2018
October 22, 2018
October 18, 2018
View More
News Commentary
Editor Image
06 Mar, 2018 | by H. Jack West, MD
With the evidence on immune checkpoint inhibitors in many cancer settings being...
View Comment
Editor Image
19 Feb, 2018 | by Winston Wong, PharmD
I lived through and was part of the payer process for many years. It is not a...
View Comment
View More
OBR Blog
There are no Kidney (Renal Cell) Cancer blog entries.